BRAF and neoplasm: To further study the effect of BRAF inhibitors on AHR expression in thyroid-originating tumor cells, the BRAFV600E carrying cell lines were treated with RAF265 or SB590885, which exert their inhibitory activity with more potency towards BRAF active conformation than the inactive one [4].